KRTL.US KRTL Holding Group Inc
- Market cap
- USD 4.73M
- P/E
- -
- P/B
- -
- ROE
- 52.9%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is KRTL.US undervalued?
Graham numberThe Graham number of KRTL Holding Group Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
KRTL Holding Group Inc fundamental analysis
No fundamental analysis for KRTL Holding Group Inc yet.
KRTL Holding Group Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About KRTL Holding Group Inc
KRTL Holding Group, Inc. operates as a diversified holding company. The company engaged in research and development of biotechnology; healthcare-related activities and intellectual property development; provides market-entry strategy, cross-border commercialization consulting, and sourcing and distribution of bio- and agri-technology products; and manages supply-chain logistics and vendor coordination. The company was formerly known as Queench, Inc. and changed its name to K…
Full company profileKRTL Holding Group Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
KRTL Holding Group Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2003 | 2004 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | - | - | - | - | - | - | 165K | 32.3K | 2.67M | 193K | 12.5K |
| Gross Profit | - | - | - | - | - | - | 165K | 32.3K | - | - | - |
| Operating Income | - | - | - | - | - | -250K | -620K | -56.5K | 2.46M | -1.21M | -424K |
| EBITDA | - | - | - | - | - | -13.4K | -455K | -132K | 1.02M | -1.21M | -424K |
| Net Income | - | - | - | - | - | -250K | -684K | -269K | 919K | -2.01M | 330K |
| EPS | - | - | - | - | - | 0.00 | -0.01 | 0.00 | 0.00 | -0.02 | 0.00 |
| Balance Sheet | |||||||||||
| Total Assets | - | - | - | - | - | - | 423K | 393K | 1.61M | 642K | 987K |
| Total Liabilities | - | - | - | - | - | - | 84.9K | 343K | 413K | 315K | 364K |
| Shareholders' Equity | - | - | 117K | - | - | - | 338K | 49.9K | 1.20M | 326K | 623K |
| Cash & Short-term Investments | - | - | - | - | - | - | 40.0K | 8.07K | 72.0K | 18.1K | 74.4K |
| Total Debt | - | - | - | - | - | - | 300.00 | 265K | 265K | 13.6K | 67.2K |
| Cash Flow | |||||||||||
| Operating Cash Flow | - | - | - | - | - | -250K | -12.3K | - | -80.2K | -300K | -159K |
| Capital Expenditure | 0.00 | 0.00 | - | - | - | 0.00 | 4.00 | - | 4.00 | 4.00 | 14.00 |
| Free Cash Flow | - | - | - | - | - | -250K | -12.3K | - | -80.2K | -300K | -159K |
| Ratios | |||||||||||
| ROE | - | - | - | - | - | - | -202.5% | -539.8% | 76.7% | -616.1% | 52.9% |
| ROA | - | - | - | - | - | - | -161.8% | -68.6% | 57.0% | -313.2% | 33.4% |
| Net Profit Margin | - | - | - | - | - | - | -413.4% | -834.3% | 34.5% | -1,043.9% | 2,637.7% |
| Debt to Equity | - | - | - | - | - | - | 0.00x | 5.31x | 0.22x | 0.04x | 0.11x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
KRTL Holding Group Inc dividends
KRTL Holding Group Inc has not paid dividends in the last 8 fiscal years.
Last stock split: 1:3 on Apr 25, 1996.
Who owns KRTL Holding Group Inc
Ownership data of KRTL Holding Group Inc is not available yet.
KRTL Holding Group Inc company profile
- Company name
- KRTL Holding Group Inc
- Ticker
- KRTL.US
- Exchange
- USA Stocks
- Sector
- Industrials
- Industry
- Beverages
- Fiscal year end
- December
- Address
- 14143 Denver W Parkway, Lakewood, CO, United States, 80401
- Phone
- 800 707 0586
- Website
- krtlholding.com
About KRTL Holding Group Inc
KRTL Holding Group, Inc. operates as a diversified holding company. The company engaged in research and development of biotechnology; healthcare-related activities and intellectual property development; provides market-entry strategy, cross-border commercialization consulting, and sourcing and distribution of bio- and agri-technology products; and manages supply-chain logistics and vendor coordination. The company was formerly known as Queench, Inc. and changed its name to KRTL Holding Group, Inc. in July 2022. KRTL Holding Group, Inc. was incorporated in 1984 and is based in Lakewood, Colorado.
KRTL Holding Group Inc management
8- Mr. Cesar HerreraCEO & COO
- Mr. Josh PierreExecutive Vice President, Secretary and General Counsel
- Mr. Keith IngramExecutive Entertainment Consultant and Director
- Mr. Jack RobinsonExecutive Entertainment Consultant and Director
- Dr. Malcolm A. Leissring Ph.D.Chief Science Officer of KRTL Biotech, Inc.
- Mr. Bret C. DeckerSecretary, General Manager and Director · born 1955
- Mr. Daniel BallChief Executive Officer of KRTL Biotech, Inc.
- Mr. Mario Anthony HernandezTreasurer & Secretary